Sort by
Refine Your Search
-
meaningful outcomes and create business impact. PHYSICAL/MENTAL REQUIREMENTS For this position, if at a site with nonhuman primates, you are expected to enter the nonhuman primate areas as part of your job
-
multidisciplinary project teams, working with colleagues to define and execute particle characterization activities for drug substances or intermediates, in line with project timelines. The position involves
-
on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or
-
lead other colleagues within the analytical group to support completion of assay verification/qualification tasks as needed. Where applicable, perform job responsibilities in compliance with GLP
-
at the center of our operations and you'll find that everything we do, every day, is in line with an unwavering commitment to quality. You will have the important role to generate high-quality immunoassay data in
-
information to health professionals, patients, and external organizations, as well as contributing to MI initiatives with Business Unit(s), Product/Therapy Area Team(s), and other platform functions in support
-
of the Oncogenic Transcriptional Networks Group within the Cancer Cell Biology (CCB) Department. The candidate should have expertise in cell line engineering technologies, molecular and protein biology methods, and
-
of our operations and you'll find that everything we do, every day, is in line with an unwavering commitment to quality. You will be part of a team that is addressing the critical task of rejuvenating our
-
effectiveness working in cross-functional business environment. Proven influencing skills Strong interpersonal skills to quickly build rapport and credibility with Pfizer leaders and key external stakeholders
-
of the United States. Relocation assistance may be available based on business needs and/or eligibility. Sunshine Act Pfizer reports payments and other transfers of value to health care providers as required by federal